Janus Henderson Group
MGNX icon

Janus Henderson Group’s MacroGenics MGNX Stock Holding History

Janus Henderson Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33,100
Closed -$141K – 2549
2024
Q2 		$141K Sell
33,100
-303
-0.9% -$2.95K ﹤0.01% 2470
2024
Q1 		$492K Buy
+33,403
New +$505K ﹤0.01% 2014

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group's MGNX Position: Q3 2024 in Review

Janus Henderson Group sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 33,100 shares — an estimated $141K sold.

Janus Henderson Group first reported a position in MGNX in Q1 2024 and held it in 2 quarters. The position peaked at $492K in Q1 2024. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Janus Henderson Group reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Janus Henderson Group sold 33,100 MacroGenics shares in Q3 2024, an estimated $141K.
  • Janus Henderson Group first reported a position in MacroGenics in Q1 2024 and held it in 2 quarters.
  • Janus Henderson Group's MacroGenics position peaked at $492K in Q1 2024.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.